A PHASE II STUDY OF MOTEXAFIN-GADOLINIUM (NSC 695238, IND 55583) AND INVOLVED FIELD RADIATION THERAPY FOR INTRINSIC PONTINE GLIOMA OF CHILDHOOD
Phase of Trial: Phase II
Latest Information Update: 06 Jan 2018
At a glance
- Drugs Motexafin gadolinium (Primary)
- Indications Glioma
- Focus Therapeutic Use
- 25 May 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 25 May 2010 Actual end date (Apr 2010) added as reported by ClinicalTrials.gov.
- 30 Jun 2009 New source identified and integrated (New Jersey Cancer Trial Connect).